News Quantified

HRTX – heron therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Heron Therapeutics (HRTX) was upgraded by Zacks Research from "strong sell" to "hold".

Heron Therapeutics (HRTX) was downgraded by Zacks Research from "hold" to "strong sell".

Heron Therapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]

Heron Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]

Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript [Seeking Alpha]

4.3%

BEAT

4.3%

MISS

-23.3%

MISS

10.0%

BEAT

Form 4 HERON THERAPEUTICS, INC. For: Apr 03 Filed by: Collard Craig A

Form 8-K HERON THERAPEUTICS, INC. For: Apr 03

Form SCHEDULE 13G/A HERON THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC

Form 10-K HERON THERAPEUTICS, INC. For: Dec 31

Form 8-K HERON THERAPEUTICS, INC. For: Feb 26

Top News Gainers

5/9 Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress 10.1%

10/28 Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain 9.0%

10/1 Heron Therapeutics Inc (NASDAQ: HRTX) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $38.00 price target on the stock, up previously from $33.00. 6.6%

2/19 Form 8-K HERON THERAPEUTICS, INC. For: Feb 18 5.8%

1/13 Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises 5.8%

10/3 Heron Therapeutics Inc (NASDAQ: HRTX) had its price target lowered by analysts at JMP Securities to $32.00. They now have a "positive" rating on the stock. 5.2%

10/4 Heron Therapeutics (HRTX) Investor Presentation - Slideshow [Seeking Alpha] 4.7%

4/17 Form 4 HERON THERAPEUTICS, INC. For: Apr 15 Filed by: Christian Waage 4.6%

11/15 Heron Therapeutics: Looking Solid Heading Into 2020 [Seeking Alpha] 3.9%

11/13 Heron Therapeutics to Present at the Stifel 2019 Healthcare Conference 3.6%

Top News Decliners

4/30 Heron Therapeutics Inc (NASDAQ: HRTX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -13.0%

10/3 Heron Therapeutics Announces Proposed Public Offering of Common Stock -8.8%

10/1 Heron Therapeutics Inc (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Cowen Inc. They now have a $40.00 price target on the stock. -6.9%

10/22 Form 8-K HERON THERAPEUTICS, INC. For: Oct 22 -5.9%

1/13 Form 8-K HERON THERAPEUTICS, INC. For: Jan 13 -5.5%

5/22 Heron Therapeutics Inc (NASDAQ: HRTX) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -4.7%

3/5 Heron Therapeutics (HRTX) Presents At SVB Leerink Global Healthcare Conference - Slideshow [Seeking Alpha] -4.5%

11/13 Heron Therapeutics Inc (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Northland Securities. They now have a $47.00 price target on the stock. -4.2%

4/9 Heron Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference -3.7%

2/25 Heron Therapeutics to Present at the 40th Annual Cowen Healthcare Conference -3.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day